By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Auspex Pharmaceuticals 

1261 Liberty Way
Suite C
Vista  California  92081-8356  U.S.A.
Phone: 760-599-1800 Fax: 760-599-1801



Company News
Auspex Pharmaceuticals Initiates Pivotal Phase 2/3 Clinical Trial For SD-809 In Tardive Dyskinesia 7/17/2014 6:41:54 AM
Auspex Pharmaceuticals Announces Completion Of Follow On Offering And Exercise Of Underwriters' Option To Purchase Additional Shares 7/17/2014 6:02:51 AM
Auspex Pharmaceuticals Announces Pricing Of Follow On Offering 7/14/2014 6:31:28 AM
Southern California's Auspex Pharmaceuticals Prices Public Offering, Aims To Raise $60.6 Million 7/11/2014 6:25:39 AM
Auspex Pharmaceuticals Announces Data From Interim Analysis Of ARC-HD Switch Trial Demonstrating Clinical Activity Of SD-809 6/24/2014 7:42:12 AM
Auspex Pharmaceuticals To Present At Jefferies and Co. Global Healthcare Conference 5/28/2014 9:51:41 AM
Auspex Pharmaceuticals Appoints Industry Veterans Lynn Bleil And Scott Greer To Its Board Of Directors 5/7/2014 7:17:23 AM
Auspex Pharmaceuticals Reports 2013 Fourth Quarter And Full Year 2013 Financial Results 3/28/2014 6:14:32 AM
Auspex Pharmaceuticals Announces Completion Of Initial Public Offering And Exercise In Full Of Underwriters' Over-Allotment Option 2/10/2014 2:42:14 PM
Auspex Pharmaceuticals Announces Pricing Of Initial Public Offering 2/5/2014 5:26:25 AM